Bone Marrow Transplant in India

A bone marrow transplant, more broadly called a hematopoietic stem cell transplant, uses blood-forming stem cells to replace or restore the patient's blood-forming system following intensive treatment.

The terms are often used interchangeably by patients.

A stem cell transplant involves transferring blood-forming stem cells. These cells can be collected from bone marrow, peripheral blood or, in some circumstances, other sources.

Transplantation may be considered for selected patients with conditions such as leukaemia, lymphoma, multiple myeloma, aplastic anaemia, myelodysplastic syndromes and certain inherited or immune disorders.

However, not every patient with these conditions requires transplantation.

An autologous transplant uses the patient's own stem cells.

An allogeneic transplant uses stem cells from another person.

The appropriate approach depends on the patient's disease and treatment plan.

Not always.

Autologous transplantation uses the patient's own stem cells.

Allogeneic transplantation requires a donor. The transplant team will assess potential donors and determine compatibility and suitability.

A family member may be a potential donor, particularly a sibling, but biological relationship does not automatically mean the donor is suitable.

The transplant team performs appropriate tissue-typing and medical assessment.

Depending on the disease and transplant programme, other donor options may sometimes be considered, including unrelated donors or partially matched family donors.

The appropriate donor strategy must be determined by the transplant team.

There is no single BMT cost.

It depends on:

Type of transplant

Underlying disease

Donor pathway

Conditioning treatment

Hospital

Length of admission

Complications

Medicines

Follow-up requirements

A specialist evaluation is necessary before a meaningful estimate can be provided.

There is no single “best” BMT hospital for every patient.

The appropriate centre depends on the patient's disease, age, transplant type, complexity and specialist requirements.

We can help identify appropriate transplant centres based on the patient's medical information.

The transplant itself is not the only part of the treatment.

The overall journey can involve evaluation, donor testing, conditioning treatment, stem-cell infusion, hospitalisation and recovery.

The duration varies substantially between patients and transplant types.

The stem-cell infusion itself is generally given through a vein and is not equivalent to a surgical operation.

However, the treatment surrounding transplantation can be physically demanding, particularly conditioning therapy and the recovery period.

The treating team should explain the expected side effects and risks for the individual patient.

Potential complications vary depending on the transplant type and the patient's condition.

They can include infection, bleeding, organ complications and, in allogeneic transplantation, graft-versus-host disease among other complications.

The transplant team should explain the individual risks before treatment.

Yes.

A second opinion from an experienced haematologist or BMT specialist can help clarify:

Whether transplantation is appropriate

Which type of transplant may be considered

Whether other treatment options exist

What donor options may be available

What risks and benefits should be considered

Depending on the condition, useful documents may include:

Bone marrow biopsy reports

Pathology reports

Blood investigations

Flow cytometry

Cytogenetic/molecular test results

PET/CT or other imaging reports

Previous chemotherapy details

Discharge summaries

HLA typing, if already performed

Current medication

If you don't have everything, don't wait.

Send the reports you have and the specialist team can advise what additional information is required.